Skip to content
Open access · CC-BY via OpenAlex

Biomarkers of Inflammatory Bowel Disease

Fengming Yi, Jian-Bing Wu

Disease Markers · 2014 · ▲ 94 citations

Abstract

Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1155/2014/710915
Canonical
link ↗
Fetched
2026-07-28 MST

Cite this

APA
Yi, F., &amp; Wu, J. (2014). Biomarkers of Inflammatory Bowel Disease. <em>Disease Markers</em>. https://doi.org/10.1155/2014/710915
Vancouver
Yi F, Wu J. Biomarkers of Inflammatory Bowel Disease. Disease Markers. 2014. doi:10.1155/2014/710915.
BibTeX
@article{fengming2014Biomar, title = {Biomarkers of Inflammatory Bowel Disease}, author = {Fengming Yi and Jian-Bing Wu}, journal = {Disease Markers}, year = {2014}, doi = {10.1155/2014/710915}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings